Connection

Radhika Gudi to CTLA-4 Antigen

Back to Details
This is a "connection" page, showing publications Radhika Gudi has written about CTLA-4 Antigen.
Radhika Gudi
Connection Strength
0.375
CTLA-4 Antigen
  1. Activation of T cell checkpoint pathways during ?-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes. Immunology. 2022 07; 166(3):341-356.
    View in: PubMed
    Score: 0.205
  2. Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance. Sci Rep. 2019 08 19; 9(1):12065.
    View in: PubMed
    Score: 0.170
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.